The emergence and spread of SARS-Cov-2 Lambda (B.1.621) variant
The global death count resulting from the coronavirus disease 2019 (COVID-19) pandemic is 4.43 million. Thus, the need to maintain […]
Severe COVID-19 is associated with massive dysregulation of the host immune response, resulting in inflammation and the condition known as […] An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been […] Researchers in Romania, the UK, and Canada have systematically reviewed the evidence available on the transmission of severe acute respiratory […] Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and […] COVID-19 (coronavirus disease 2019) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), displaying high mortality rates. Responsible for […] Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. We know that mutations in the genome of SARS-CoV-2 have occurred […] Evolutionary ecology theory offers avenues to anticipate the future behavior of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. […]Sars-CoV-2
Human tissue xenografts in murine models for the study of SARS-CoV-2
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
Risk of SARS-CoV-2 transmission aboard aircraft is low: A review of evidence
Plant-based vaccine against SARS-CoV-2 shows promise
A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations
Can universal vaccines and treatments against future SARS-CoV-2 variants be developed?